Senior Care News

MUNDELEIN, IL–(Marketwire – September 29, 2010) –  Despite traditional differences among the chief constituents of long-term care, the new survey process can be a “win-win” for everyone, which will drive significant quality improvements in our nation’s nursing homes, said Kansas Governor Mark Parkinson and the incoming president of the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), the nation’s largest long-term care association. Governor Parkinson made these comments while speaking at Medline Industries, Inc.’s second annual Long-Term Care Quality Summit, in New York City. More than 150 leaders from the nation’s long-term care community are attending the two-day forum focused on how nursing homes can meet the changing expectations for quality among their residents and families.

“Historically there has been mistrust among providers, regulators and advocacy groups over the traditional survey process and what its goals are,” said Governor Parkinson. “But I am optimistic now because we all want quality care in our nursing homes, and the new Quality Indicator Survey (QIS) process can help make this happen.”

Governor Parkinson said the QIS is more objective than the traditional survey process and focuses on important quality criteria, including a robust care plan, promoting a safe environment and keeping residents active. He emphasized that for resident quality to improve, it was crucial that these criteria be measured and homes be held accountable to maintaining high standards.

In addition to Governor Parkinson, topics being discussed at the Summit include the changing regulatory expectations for the long-term care industry and how nursing homes can implement a system to continuously improve quality of care and life for their residents.

Other speakers include: Anthony Rodgers, new CMS Deputy Administrator for the Center for Strategic Planning; Robert F. Kennedy, Jr.; Andy Kramer, MD, chief executive officer of Nursing Home Quality and professor of medicine, University of Colorado; Neil Pruitt, Jr., chairman and CEO, UHS Pruitt Corporation; Jim Foy, president and CEO, St. John’s Riverside Healthcare System, Yonkers, NY; Barbara Baylis, senior vice president of clinical operations, Kindred Healthcare, Inc.; Mary Ousley, president of Ousley & Associates; Elizabeth Ayello, president of Ayello, Harris and Associates; and Kevin Yankowsky, partner in the health law litigation group of Fulbright & Jaworski L.L.P.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

CHICAGO, IL–(Marketwire – September 27, 2010) –   Ziegler (PINKSHEETS: ZGCO), a specialty investment banking firm serving hospital and healthcare systems clients since 1928, announced the promotion of John Hanley to the head of its healthcare investment banking practice. Hanley, most recently a managing director in Ziegler’s healthcare practice, will lead the healthcare team in its continued delivery of capital advisory and investment banking services to non-profit hospitals and healthcare systems throughout the country.

Tom Paprocki, CEO of Ziegler, comments about Hanley’s promotion, “John has been an integral part of our healthcare team at Ziegler for many years. He’s an excellent relationship banker and has consistently demonstrated the leadership and vision necessary to head-up our healthcare practice.”

Hanley offered, “Ziegler’s continuous commitment to the healthcare industry over the past 75+ years has resulted in many long-established relationships and new business opportunities. In addition, the expansion of our sales and trading business over the past two years has provided significantly enhanced bond distribution for our clients. I am very excited to have the opportunity to lead our team going forward.”

For more information about Ziegler, please visit us at www.Ziegler.com.

About Ziegler:
The Ziegler Companies, Inc. (PINKSHEETS: ZGCO) together with its affiliates (Ziegler) is a specialty investment bank with unique expertise in complex credit structures and advisory services. Nationally, Ziegler is ranked as one of the leading investment banking firms in its specialty sectors of healthcare, senior living, religion and education finance, as well as corporate finance and FHA/HUD. Headquartered in Chicago, IL with regional and branch offices throughout the U.S., Ziegler creates tailored financial solutions including bond financing, advisory, private placement, seed capital, M&A, risk and asset management. Ziegler serves institutional and individual investors through its wealth management and capital markets distribution channels.

Certain comments in this news release represent forward-looking statements made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to a number of risks and uncertainties, in particular, the overall financial health of the securities industry, the strength of the healthcare sector of the U.S. economy and the municipal securities marketplace, the ability of the Company to underwrite and distribute securities, the market value of mutual fund portfolios and separate account portfolios advised by the Company, the volume of sales by its retail brokers, the outcome of pending litigation, and the ability to attract and retain qualified employees.

IRVINE, CA–(Marketwire – September 23, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) (“Sun”) announced today that it intends to refinance its existing senior secured credit facilities with borrowings under a new senior secured credit facility to be entered into by SHG Services, Inc., a subsidiary of Sun (“SHG”). The new senior secured facility is expected to include a $60 million revolving credit facility, a $150 million term loan and a $75 million funded letter of credit facility. The refinancing, which is being undertaken in connection with Sun’s previously announced restructuring, is subject to market and other conditions, and there can be no assurances that these transactions will be consummated.

About Sun Healthcare Group, Inc.

Sun’s subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary.

In May 2010, Sun announced a plan to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies through a series of internal restructurings (the “Restructuring”), subject to the approval of stockholders and other conditions. In connection with the Restructuring, SHG will own and continue to operate all of Sun’s operating subsidiaries, with stockholders of Sun receiving a pro rata distribution of the stock of SHG (the “Separation”). Substantially all of Sun’s currently-owned real estate assets will be owned by Sabra Health Care REIT, Inc., a subsidiary of Sun (“Sabra”) and, immediately after the Separation, Sun will merge into Sabra. Following this merger, SHG will change its name to Sun Healthcare Group, Inc. The common stock of both companies is expected to trade on the NASDAQ Global Select Market. The Restructuring (including the Separation) is expected to be completed in the fourth quarter of 2010.

Forward-Looking Statement

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Forward-looking statements in this release include all statements regarding our expected future financial position and results of operations, business strategy, the impact of reductions in reimbursements and other changes in government reimbursement programs, the timing and impact of the Separation and transactions related thereto, growth opportunities and plans and objectives of management for future operations. Factors that could cause actual results to differ are identified in the public filings made by Sun with the Securities and Exchange Commission and include changes in Medicare and Medicaid reimbursements; the impact that any healthcare reform legislation will have on our business; our ability to maintain the occupancy rates and payor mix at our healthcare centers; potential liability for losses not covered by, or in excess of, our insurance; the effects of government regulations and investigations; the significant amount of our indebtedness, covenants in our debt agreements that may restrict our activities and our ability to make acquisitions, to incur more indebtedness and to refinance indebtedness on favorable terms; our ability to accomplish the Separation and the transactions related thereto, the impact of the current economic downturn on our business; increasing labor costs and the shortage of qualified healthcare personnel; and our ability to receive increases in reimbursement rates from government payors to cover increased costs. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Forms 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. There may be additional risks of which we are presently unaware or that we currently deem immaterial.

The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance and are only made as of the date of this release. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

Additional Information

In connection with the Separation, SHG has filed with the SEC a Registration Statement on Form S-1 and Sabra has filed with the SEC a Registration Statement on Form S-4, each containing an identical proxy statement/prospectus. The definitive proxy statement/prospectus will be mailed to Sun stockholders. Before making any voting or investment decision, Sun stockholders and investors are urged to read the proxy statement/prospectus and other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about the proposed transactions. Stockholders will be able to obtain these documents free of charge at the SEC’s web site at www.sec.gov. In addition, investors and stockholders of Sun may obtain free copies of the documents filed with the SEC by contacting Sun’s investor relations department at (505) 468-2341 (TDD users, please call (505) 468-4458) or by sending a written request to Investor Relations, Sun Healthcare Group, Inc. 101 Sun Avenue N.E., Albuquerque, N.M. 87109.

Sun and its directors and executive officers and other members of its management and employees may be deemed to be participants in the solicitation of proxies from the stockholders of Sun in connection with the transactions described in this release. Information about the directors and executive officers of Sun and their ownership of shares of Sun common stock are set forth in the Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 5, 2010, and in the definitive proxy statement relating to Sun’s 2010 Annual Meeting of Stockholders filed with the SEC on April 30, 2010. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of these participants will also be included in the definitive proxy statement/prospectus when it becomes available.

BALTIMORE, MD–(Marketwire – September 21, 2010) –  The Harry and Jeanette Weinberg Foundation, one of the largest private foundations in the United States, today celebrates the largest gift to a long-term care center in the Foundation’s history.

The $10 million pledge is part of a $31 million construction project at Levindale Hebrew Geriatric Center and Hospital that will set a new standard for excellence in elder care. The occasion will be marked with a ceremony Tuesday, September 21, at 5 p.m. on the newly named Harry and Jeanette Weinberg campus at Levindale.

“Harry Weinberg was always concerned about the lives of poor older adults, and his commitment is carried out by the Foundation which bears his name,” said Barry I. Schloss, the Foundation treasurer, and one of its trustees. “The Foundation is proud to partner with Levindale on this groundbreaking project.”

With completion expected in the spring of 2012, the new Levindale will be a cheerful, inviting residence providing a comfortable, elegant and friendly atmosphere.

The Harry and Jeanette Weinberg Foundation is dedicated to assisting the poor, meeting basic needs such as shelter, nutrition, and health with special emphasis on older adults and the Jewish community.

About The Harry and Jeanette Weinberg Foundation
The Harry and Jeanette Weinberg Foundation annually distributes approximately $100 million to a wide range of charitable organizations. The Foundation is dedicated to assisting the poor through operating and capital grants to direct service organizations primarily located in Maryland, Hawaii, Northeastern Pennsylvania, New York, Israel, and the Former Soviet Union. Grants are focused on meeting basic needs such as shelter, health and socialization, nutrition, and on enhancing an individual’s ability to meet those needs. Within that focus, emphasis is placed on older adults and on the Jewish community. The trustees, some of whom also serve as executive officers of the Foundation, are Alvin Awaya, Judge Ellen M. Heller, Robert T. Kelly, Jr., Barry I. Schloss, and Chair of the Board Donn Weinberg. Rachel Monroe serves as the Weinberg Foundation’s President. For more information please go to www.hjweinbergfoundation.org.

MARYVILLE, TN–(Marketwire – September 21, 2010) –  Asbury, Inc. announced that it will break ground on its St. Clair Apartments project at Asbury Place Maryville today. The groundbreaking will take place at 10:00 a.m. at the Asbury Place Maryville campus, 2648 Sevierville Road, Maryville, TN. The ceremony will include local officials and staff. Staff members who have been with Asbury for twenty or more years will also be honored. The public is invited.

With an estimated construction cost of $6 million, St. Clair Apartments at Asbury Place includes 48 new residential apartment homes, a new Wellness Center and Dining Room, and renovations to the existing Clubhouse.

The apartments will range in size from 900 to more than 1700 square feet, and residents have a choice of 1, 2 or 3-bedroom floor plans with walk-in closets, full kitchens, telephone, internet and cable hookups, built-in garbage disposals, dishwashers, washers and dryers and central heating and air. Other features include choice of interior colors, window treatments, skylights on upper floors, pocket doors, tray ceilings, optional fireplaces, smoke detection and sprinklers, screened porches, elevators, and under building garages with automatic door openers.

The groundbreaking is a milestone in making true enhancements to the retirement lifestyle at Asbury. Bistro-style and private dining, a brand-new Wellness Center, and fitness classes combine to make tangible Asbury’s vision of a person-centered approach to overall wellness.

“St. Clair is a direct response to what people fifty-five and better are looking for in residences at a community. Residences are becoming more personalized and customized, and they have accents and finishes that rival other new home construction. Senior living communities are upgrading their wellness centers in response to more residents focusing on fitness and a dedication to staying healthy longer. Restaurant-style and quality dining is also now the norm, including having an executive chef, fresh ingredients and more menu choices,” said Joy Evans, The Asbury Group’s Regional Director of Marketing.

Tesa Brown, Asbury Place Maryville Executive Director, added, “This is a much-anticipated day for Asbury Place Maryville. Residents at St. Clair will have an active lifestyle, a better lifestyle, and it’s exciting to see all the planning become reality. Asbury Place Maryville has a full continuum of on-site care, and St. Clair is now a significant part of that.”

Joseph Construction of Knoxville is the construction consultant and anticipates as many as 125 workers will be employed for the project.

Reservations are now being accepted for the apartments, and a welcome center on the Asbury campus provides further information. For a limited time, those who reserve a new apartment home receive Charter Member benefits, including the best selection of residential living style and location, preferential pricing, and invitations to special Members-only events.

About Asbury, Inc.
Founded in 1956, Asbury, Inc. manages a network of not-for-profit retirement communities and health care centers for individuals fifty-five or better in Maryville, Kingsport, and Johnson City, Tennessee. For more information, please visit http://www.AsburyPlaceExpansion.com or call (865) 238-8304.

Click here to see all recent news from this company

MARKHAM, ONTARIO–(Marketwire – Sept. 15, 2010) – Leisureworld Senior Care Corporation (TSX:LW) today announced that the Company’s dividend for September, 2010 will be $0.0708 per share, representing $0.85 per share on an annualized basis. Payment will be made on October 15, 2010 to shareholders of record September 30, 2010.

About Leisureworld

Leisureworld is the third largest licensed long-term care (LTC) provider in Ontario. The Company owns and operates 26 LTC homes, representing approximately 4,314 beds across Ontario, Canada. Leisureworld also owns and operates one retirement home with 29 beds and one independent living home with 53 apartments. Leisureworld subsidiaries include: Preferred Health Care Services, an accredited provider of professional nursing and personal support services, Ontario Long Term Care, a provider of purchasing services, dietary, social work, and other regulated health professional services, and Tealwood Developments, a provider of laundry services to the Leisureworld Homes.

PALMETTO, FL–(Marketwire – September 14, 2010) –  TrinityCare Senior Living (OTCBB: TCSR) today announced that it has completed the transaction anticipated in a definitive agreement for a business combination via the acquisition of 100% of the outstanding capital stock of SeaBridge Freight, Inc., a Tampa Bay area based company which is the pioneer in creating the U.S. Marine Highway Industry, providing the most environmentally friendly, safe, cost efficient container-on-barge, blue water, intermodal freight service through geographical advantaged routes. The stockholders of SeaBridge received newly issued shares of common stock of TrinityCare; management of SeaBridge assumed their role as management of TrinityCare and commenced the process of changing the corporate name to SeaBridge Freight Corp.

“This business combination with SeaBridge Freight is a significant milestone for TrinityCare Senior Living, Inc. that is crucial to the future success of the Company. We fully believe in their business model providing smart, efficient and environmentally friendly freight services to strategic markets, and are excited to be part of the future of SeaBridge Freight as shareholders,” stated Donald W. Sapaugh, former Chairman and Chief Executive Officer of TrinityCare Senior Living, Inc.

About TrinityCare Senior Living

TrinityCare Senior Living (“TrinityCare”) develops, owns, and manages quality senior living facilities that focus on enriching the faith of the residents and providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. TrinityCare operates three facilities in Texas and Tennessee. For more information please visit www.trinitycare.com.

About SeaBridge Freight Corp.

SeaBridge Freight Corp. is the pioneer in creating the U.S. Marine Highway Industry, providing the most environmentally friendly, safe, cost efficient container-on-barge, blue water, intermodal freight service through geographical advantaged routes. The Company provides container-on-barge, break-bulk and out-of-gauge freight transport service between Port Manatee of Tampa Bay, FL and Port Brownsville, Texas. Utilizing a direct water route that is drastically shorter than a land route, the Company presents a more environmentally friendly alternative that economically connects the Mexico/ South Texas and Southeastern US markets. As a reliable alternative freight transportation option for shippers the Company’s services can be integrated with third party logistics providers, truckers and intermodal rail carriers to significantly lower freight costs. SeaBridge Freight Corp is headquartered in Palmetto, Florida.

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company’s periodic filings with the Securities and Exchange Commission.

PEARL RIVER, NY–(Marketwire – September 13, 2010) –  Sanford “Sandy” Elsass, President of Uni-Ter Underwriting Management Corporation (UUMC), has been elected a Director of U.S. RE Companies, Inc., an international financial services and reinsurance brokerage firm, Tal P. Piccione, Chairman and Chief Executive Officer, announced.

UUMC is a subsidiary of U.S. RE Companies that builds and manages Risk Retention Groups in the healthcare industry. The RRGs provide general and professional liability insurance to long-term care facilities, physicians/surgeons, nurses, other healthcare professionals, and related businesses in 48 states. Elsass joined the U.S. RE Group in 2002. He also serves as a senior officer of U.S. RE.

“Sandy Elsass has built Uni-Ter into a major profit center. His rich experience in brokerage management and investment banking will be invaluable to our Board as U.S. RE grows,” Piccione said.

Elsass has been in the insurance industry and related business for 30 years. He serves currently as a Director of the Nevada Captive Insurance Association, the National Risk Retention Association, and Sunshine State Insurance Company of Florida. Prior to joining U.S. RE, he was an investment banker with Marsh Berry and Company. Earlier, he was President of Montgomery & Collins, a wholesale insurance broker that was sold to Marsh & McLennan. Elsass is a former Director of Wainwright Bank & Trust Company, Boston. He is a graduate of Ohio University.

Click here to see all recent news from this company

SPRINGFIELD, OH–(Marketwire – September 2, 2010) –  AdCare Health Systems, Inc. (NYSE Amex: ADK), a recognized innovator in senior living and health care facility management, has closed the lease of three nursing homes according to the previously announced agreement to lease five additional nursing homes in Georgia.

The three nursing homes, which have been leased under a 10-year term, have an aggregate of 280 beds that generate approximately $15.5 million in annualized revenue. With the addition of these three facilities and other transactions closed earlier in the year, AdCare’s estimated annualized revenue run-rate now exceeds $79 million, as compared to $26.7 million for the year ended 2009.

Upon closing of the lease transaction, AdCare provided the lessor $195,000 for the first month’s lease payment and a portion of the security deposit, with the balance of $337,000 to be paid over five months comprising the balance of the security deposit and an amount equal to two months lease payments.

“This transaction is the third we’ve closed since we began our M&A campaign at the end of last year,” said Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer. “We expect all of these facilities to be significant cash generators for AdCare, especially as they come under our highly capable management and benefit from our larger economy of scale.”

“As we work toward closing the currently pending transactions we’ve announced, including the lease of the remaining two nursing homes in Georgia, additional opportunities continue to emerge in the southern region of the U.S.,” said Brogdon. “We are working to establish the terms and necessary financings for several new potential acquisitions in our pipeline of equal or greater potential.”

Brogdon joined AdCare last September when the company announced a new M&A growth strategy to build upon its strong reputation for operational efficiency and high-quality living environments.

About AdCare Health Systems
AdCare Health Systems, Inc. (NYSE Amex: ADK) is a recognized innovator in senior living and health care facility management. AdCare develops, owns and manages assisted living facilities, nursing homes and retirement communities, as well as provides home health care services. Since its inception in 1988, AdCare’s mission has been to provide the highest quality of healthcare services to the elderly. For more information about AdCare, visit www.adcarehealth.com.

Important Cautions Regarding Forward-Looking Statements
 Statements contained in this press release that are not historical facts may be forward-looking statements within the meaning of federal law. Such statement can be identified by the use of forward-looking terminology, such as “believes,” “expects,” “plans,” “intends,” “anticipates” and variations of such words or similar expressions, but their absence does not mean that the statement is not forward-looking. Statements in this announcement that are forward-looking include, but are not limited to, statements that the company expects all of these new facilities to be significant cash generators for AdCare. Such forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available to management. The forward-looking statements involve known and unknown risks, results, performance or achievements of the Company to differ materially from those expressed or implied in such statements. Such factors are identified in the public filings made by the Company with the Securities and Exchange Commission and include the Company’s ability to secure lines of credit and/or an acquisition credit facility, find suitable acquisition properties at favorable terms, changes in the health care industry because of political and economic influences, changes in regulations governing the industry, changes in reimbursement levels including those under the Medicare and Medicaid programs and changes in the competitive marketplace. There can be no assurance that such factors or other factors will not affect the accuracy of such forward-looking statements.

Click here to see all recent news from this company

TORONTO, ONTARIO–(Marketwire – Aug. 30, 2010) – Sunnybrook Health Sciences Centre will offer people a sneak peak of its greatly anticipated, new birthing facilities and neonatal intensive care units. Sunnybrook’s new facilities encompass more than 120,000 sq. ft. of space making it one of the largest and most comprehensive facilities of its kind in Canada. The Women & Babies Program will deliver 4,250 babies every year in this new space and will care for 1 of every 5 babies born in Ontario who weigh less than 3 pounds.

FRIENDSWOOD, TX–(Marketwire – August 26, 2010) –  TrinityCare Senior Living, Inc. (OTCBB: TCSR), which develops, manages and owns faith-based senior living facilities, today announced the execution of an agreement with SeaBridge Freight, Inc., a Delaware company, which provides container-on-barge transport service between Port Brownsville, Texas and Tampa Bay, Florida.

“This agreement will create a change in focus for our public company, and a change we believe will be beneficial to our shareholders,” stated Donald W. Sapaugh, Chairman and Chief Executive Officer of TrinityCare Senior Living, Inc. “SeaBridge Freight, is a leader as a ‘Marine Highway,’ with revenues increasing each quarter this year. The company has excellent leadership and is poised to expand rapidly over the next year.”

This reorganization agreement has been approved by a majority of the shareholders of both companies, and further information will be available shortly.

About TrinityCare Senior Living, Inc.

TrinityCare Senior Living (“TrinityCare”) develops, owns, and manages quality senior living facilities that focus on enriching the faith of the residents and providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. The Company partners with local churches and developers for each facility and offers a wide range of both community and personal services to residents. TrinityCare is a rapidly growing company with three successful facilities currently operating in Texas and Tennessee. Near-term expansion plans target the Southeastern part of the United States. For more information please visit www.trinitycare.com.

TrinityCare is headquartered in Friendswood, Texas (Houston metropolitan area) and its common stock trades on the OTC Bulletin Board under the symbol “TCSR.”

Forward-Looking Statements

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements related to the future financial performance of the Company. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful execution of growth strategies, product development and acceptance, the impact of competitive services and pricing, general economic conditions, and other risks and uncertainties described in the Company’s periodic filings with the Securities and Exchange Commission.

CONCORD, ONTARIO–(Marketwire – Aug. 20, 2010) – Futuremed Healthcare Income Fund (TSX:FMD.UN) today announced the monthly cash distribution for August 2010 has been set at $0.0771 per unit, or $0.925 per unit on an annualized basis.

The distribution will be paid on September 15^th, 2010, to unit holders of record as at August 31^st, 2010.

Futuremed is Canada’s leading value-added distributor of consumable nursing home supplies and specialized furniture and equipment to the growing long-term care facilities sector.

CONCORD, ONTARIO–(Marketwire – Aug. 20, 2010) – Futuremed Healthcare Income Fund (TSX:FMD.UN) today announced the monthly cash distribution for August 2010 has been set at $0.0771 per unit, or $0.925 per unit on an annualized basis.

The distribution will be paid on September 15^th, 2010, to unit holders of record as at August 31^st, 2010.

Futuremed is Canada’s leading value-added distributor of consumable nursing home supplies and specialized furniture and equipment to the growing long-term care facilities sector.

NEW YORK, NY–(Marketwire – August 20, 2010) –  The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment. 

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

• minimal invasiveness,
• rapid imaging processing time,
• low imaging cost,
• low radiation dose, and
• optimal resolution and contrast.

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, “Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging),” contains more information on market forecasts, company profiles, and trends in the molecular imaging market. The report is available at:
http://www.kaloramainformation.com/redirect.asp?progid=79480&productid=2613825.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

NEW YORK, NY–(Marketwire – August 20, 2010) –  The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment. 

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

• minimal invasiveness,
• rapid imaging processing time,
• low imaging cost,
• low radiation dose, and
• optimal resolution and contrast.

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, “Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging),” contains more information on market forecasts, company profiles, and trends in the molecular imaging market. The report is available at:
http://www.kaloramainformation.com/redirect.asp?progid=79480&productid=2613825.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

NEW YORK, NY–(Marketwire – August 20, 2010) –  The cost-savings associated with early disease detection and clinicians’ demand for better, more accurate diagnostic tools are key drivers for a predicted 5.8% yearly increase in the market for molecular imaging devices. According to a new report by healthcare market research publisher Kalorama Information, this market is expected to reach $6.6 billion by 2014.

Differing from traditional diagnostic tools, molecular imaging devices use biomarkers, which produce finer images that display molecular changes, allowing physicians to pinpoint diseases. Devices include nuclear medicine based PET, which renders metabolic information, and SPECT, which produces anatomical images. These devices are well known for their ability to detect the molecular basis of diseases, including neurological and cardiovascular based diseases. In tumors, they detect chemical signatures that provide an early warning. In addition, advances in these devices have recently helped to identify vulnerable plaque in at-risk cardiac patients. Kalorama notes that combining new molecular contrast agents with traditional diagnostic tools, such us Ultrasound, MRI and CT has enabled physicians to capture specific molecular pathways to track the progress of treatment. 

While rapid advances in molecular imaging devices are pushing growth, physicians are even quicker to demand better products with:

• minimal invasiveness,
• rapid imaging processing time,
• low imaging cost,
• low radiation dose, and
• optimal resolution and contrast.

“Meeting the growing demand for a better molecular imaging device is a big driver for companies seeking to break into this market,” says Bruce Carlson, publisher of Kalorama Information. “The market could even grow further if physicians’ demands are met and we see a rise in patient confidence, as this could translate into more individuals opting in for these services.”

The adoption of molecular imaging equipment is not exclusive to physicians, according to Kalorama. Pharmaceutical and biotechnology companies are also utilizing molecular imaging equipment, as it allows them to test drug candidates in vivo for mechanisms, disposition and efficacy. The big players, such as Siemens, GE Healthcare, Phillips, and Toshiba are teaming up with contrast media companies to develop the next generation of molecular imaging equipment.

Kalorama Information’s report, “Molecular Imaging Markets (Market Intelligence Analysis of Market Opportunities in Molecular Imaging),” contains more information on market forecasts, company profiles, and trends in the molecular imaging market. The report is available at:
http://www.kaloramainformation.com/redirect.asp?progid=79480&productid=2613825.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

MADISON, WI–(Marketwire – August 19, 2010) – TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, announced today that its Co-Founder and Chairman of the Board, Thomas Rockwell “Rock” Mackie, Ph.D., will be awarded honorary membership into the European Society for Therapeutic Radiology and Oncology (ESTRO) at ESTRO 29, the organization’s bi-annual meeting, September 12-16, 2010 in Barcelona.

In addition to being honored for his scientific contributions to the field of radiation oncology, Dr. Mackie also will speak at the conference on September 13, 2010. Dr. Mackie’s lecture — titled “Can closing the visualization gap make cancer a chronic disease?” — will address how the integration of low dose, quantitative daily imaging into the radiation therapy treatment process can open opportunities for more aggressive, targeted and personalized approaches to cancer care.

Dr. Mackie’s lecture is part of a comprehensive scientific program created by ESTRO for its 29^th bi-annual meeting. The program has been designed to offer the most relevant and cutting edge science and education in radiation oncology, radiation biology and radiation physics. With a focus on clinical trials, new technology and its clinical implementation, the conference is designed to promote interdisciplinary collaboration.

“I am very proud and humbled to be awarded an honorary membership to ESTRO, an organization committed to helping its members assess and understand new technologies through the lens of patient benefit,” said Dr. Mackie. “I look forward to attending the 29^th bi-annual meeting in Barcelona, and to presenting my thoughts on the role of integrated imaging in modern radiation therapy.”

About TomoTherapy Incorporated 
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy^® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art^® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD^™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile^™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Click here to see all recent news from this company

POMONA, CA–(Marketwire – August 18, 2010) –  Western University of Health Sciences has surpassed its Capital Campaign goal of $35 million, but the work is far from over.

“We are very grateful for the support we have received for the Capital Campaign and, by extension, for our goal of building one of the most comprehensive academic health science centers in the nation,” said WesternU President Philip Pumerantz, PhD. “We also know that we must continue to build partnerships and raise awareness of our innovative programs, world-class facilities and skilled faculty and students.”

The Capital Campaign had a six-year goal of raising $35 million by WesternU’s 35^th anniversary in 2012, which was reached with two years to spare. The campaign has raised $36.5 million from about 1,600 donors as of July 2010. About $27 million has already been received, with the balance pledges to be paid before June 2012.

“This is real money that is in,” said Thomas Fox, PhD, Senior Vice President for Advancement. “Now we’ll see how far we can go.”

The Capital Campaign Case Statement set fundraising goals for specific categories, including $12.5 million for infrastructure, $8.75 million for student support and $7 million for faculty support. In the next two years, University Advancement will continue to raise money and ensure fundraising goals for each category are met, Fox said.

“Student scholarships are important. As we continue to emerge as a research organization, faculty support will be important,” he said. “With the Patient Care Center, health care strategy is another one we will look for as well.”

The Capital Campaign has reached out to new donors large and small. The $100 million campus expansion has helped raise interest in the Capital Campaign and provides many naming opportunities. The start of four new colleges in the past year allowed WesternU to tap into new prospects, Fox said.

“It is important to add donors,” he said. “We’re adding people who have never given to the university before. The message is getting out there.”

FRIENDSWOOD, TX–(Marketwire – August 17, 2010) – TrinityCare Senior Living, Inc. (OTCBB: TCSR) (the “Company”), which develops, manages and owns faith-based senior living facilities, today announced its operating results for the second quarter of 2010. 

For the six months ended June 30, 2010, the Company reported gross revenues of $3,461,586, which represented an increase of 10% when compared with gross revenues of $3,141,804 in the six months of 2009. Gross profit totaled $2,200,112, compared with $1,847,555 for the six months ended June 30, 2009. The Company’s gross profit margin reflected 62% of gross revenue in the most recent six month period, versus 65% in same period of the prior-year. The Company reported a net loss of ($402,191), or ($0.03) per share for the six months ending June 30, 2010, versus a net loss of ($721,167), or ($0.47) per share, in the prior-year period.

“This represents our fifth consecutive quarter of revenue growth, when compared with prior-year periods,” stated Donald W. Sapaugh, Chairman and Chief Executive Officer of TrinityCare Senior Living, Inc. “Our occupancy rates remain stable, and with revenues increasing, we expect the Company’s operating results to improve as we focus on controlling expenses. Existing operations are critical to our long-term success, and we have devoted significant resources to ensuring that our financial metrics improve in coming quarters. During the most recent quarter we have expanded our services to include management of facilities which are not owned by TrinityCare and we expect continued growth in that segment of our business in the near future.”

About TrinityCare Senior Living, Inc.

TrinityCare is a rapidly growing company that develops, owns and manages quality senior living facilities that focus on enriching the faith of residents while providing state-of-the-art independent living, assisted living, memory care and adult day care services in a single location. The Company partners with local churches and developers for each facility and offers a wide range of both community and personal services to residents. 

Headquartered in Friendswood, Texas, the Company currently operates three successful facilities in Texas and Tennessee. Near-term expansion plans are focused upon markets in the Southeastern U.S. For additional information, please visit www.trinitycare.com.

(Financial Highlights Follow)

TAMPA, FL–(Marketwire – August 16, 2010) –  Zimek Technologies (www.zimek.com) is pleased to announce today the addition of James Lee Witt, Chief Executive Officer of Witt Associates, as Senior Advisor at Zimek, the industry leader in infection control and biohazard remediation systems. Witt was Cabinet-level Director of FEMA (Federal Emergency Management Agency) during the Clinton Administration.

As a Senior Advisor to Zimek Technologies, Witt will work closely with Advisory Board members including former Illinois State Senate President Emil Jones Jr.; Dr. Brad Spellberg, infectious disease specialist at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center; Dr. Peder Bo Nielsen, consultant in Microbiology with the United Kingdom’s North West London NHS Trust; and Dr. Lindsey Shaw, Assistant Professor of Molecular Microbiology at the University of South Florida.

“Zimek Technologies is thrilled to have James Lee Witt join our team,” stated Kurt Grosman, CEO of Zimek. “Having Mr. Witt onboard is a testament to the effectiveness of our products and the need for stronger decontamination protocols. He will provide unprecedented leadership in the growth of our company.” Zimek’s sophisticated three-dimensional touch-less decontamination technology is being implemented in many facilities nationwide to effectively prevent the spread of deadly viruses and bacteria.

Witt’s firm recently joined the support and recovery operations of Gulf Coast communities in the wake of the oil and gas spill in the Gulf of Mexico. Witt currently serves as a Special Advisor to the State of Louisiana, assisting with the nation’s largest long-term recovery effort in the aftermath of Hurricanes Katrina and Rita.Witt Associates, a public safety and crisis management consulting firm based in Washington D.C., focuses on disaster recovery and mitigation management services to state and local governments, educational institutions, the international community and corporations.

“There must be a stronger focus on prevention of infection, not just remediation after the infection occurs,” Witt added. “Decontamination can play a larger role in our efforts to combat deadly viral and bacterial infections, and is giving us a powerful new tool in the arsenal to fight biohazard attacks.”

Zimek Technologies, based in Tampa, Florida, has been developing and marketing its patented automatic Micro-Mist^® decontamination technologies for more than five years. Zimek’s industry-leading technologies are used by the U.S. Department of Homeland Security, fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities, and local law enforcement agencies across America.